The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Methotrexate Market Research Report 2025
Synopsis
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
The global Methotrexate market was valued at US$ 517.2 million in 2023 and is anticipated to reach US$ 624.6 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
This report aims to provide a comprehensive presentation of the global market for Methotrexate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methotrexate.
Report Scope
The Methotrexate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methotrexate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methotrexate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Segment by Type
Methotrexate for Injection
Methotrexate Tablets
Segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Methotrexate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Methotrexate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
The global Methotrexate market was valued at US$ 517.2 million in 2023 and is anticipated to reach US$ 624.6 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
This report aims to provide a comprehensive presentation of the global market for Methotrexate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methotrexate.
Report Scope
The Methotrexate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methotrexate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methotrexate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Segment by Type
Methotrexate for Injection
Methotrexate Tablets
Segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Methotrexate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Methotrexate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Methotrexate Market Overview
1.1 Product Overview and Scope of Methotrexate
1.2 Methotrexate Segment by Type
1.2.1 Global Methotrexate Market Value Comparison by Type (2024-2030)
1.2.2 Methotrexate for Injection
1.2.3 Methotrexate Tablets
1.3 Methotrexate Segment by Application
1.3.1 Global Methotrexate Market Value by Application: (2024-2030)
1.3.2 Used for Cancers
1.3.3 Used for Rheumatoid Arthritis
1.3.4 Used for Other Diseases
1.4 Global Methotrexate Market Size Estimates and Forecasts
1.4.1 Global Methotrexate Revenue 2019-2030
1.4.2 Global Methotrexate Sales 2019-2030
1.4.3 Global Methotrexate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Methotrexate Market Competition by Manufacturers
2.1 Global Methotrexate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Methotrexate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Methotrexate Average Price by Manufacturers (2019-2024)
2.4 Global Methotrexate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Methotrexate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Methotrexate, Product Type & Application
2.7 Methotrexate Market Competitive Situation and Trends
2.7.1 Methotrexate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Methotrexate Players Market Share by Revenue
2.7.3 Global Methotrexate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Methotrexate Retrospective Market Scenario by Region
3.1 Global Methotrexate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Methotrexate Global Methotrexate Sales by Region: 2019-2030
3.2.1 Global Methotrexate Sales by Region: 2019-2024
3.2.2 Global Methotrexate Sales by Region: 2025-2030
3.3 Global Methotrexate Global Methotrexate Revenue by Region: 2019-2030
3.3.1 Global Methotrexate Revenue by Region: 2019-2024
3.3.2 Global Methotrexate Revenue by Region: 2025-2030
3.4 North America Methotrexate Market Facts & Figures by Country
3.4.1 North America Methotrexate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Methotrexate Sales by Country (2019-2030)
3.4.3 North America Methotrexate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Methotrexate Market Facts & Figures by Country
3.5.1 Europe Methotrexate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Methotrexate Sales by Country (2019-2030)
3.5.3 Europe Methotrexate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Methotrexate Market Facts & Figures by Country
3.6.1 Asia Pacific Methotrexate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Methotrexate Sales by Country (2019-2030)
3.6.3 Asia Pacific Methotrexate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Methotrexate Market Facts & Figures by Country
3.7.1 Latin America Methotrexate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Methotrexate Sales by Country (2019-2030)
3.7.3 Latin America Methotrexate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Methotrexate Market Facts & Figures by Country
3.8.1 Middle East and Africa Methotrexate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Methotrexate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Methotrexate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Methotrexate Sales by Type (2019-2030)
4.1.1 Global Methotrexate Sales by Type (2019-2024)
4.1.2 Global Methotrexate Sales by Type (2025-2030)
4.1.3 Global Methotrexate Sales Market Share by Type (2019-2030)
4.2 Global Methotrexate Revenue by Type (2019-2030)
4.2.1 Global Methotrexate Revenue by Type (2019-2024)
4.2.2 Global Methotrexate Revenue by Type (2025-2030)
4.2.3 Global Methotrexate Revenue Market Share by Type (2019-2030)
4.3 Global Methotrexate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Methotrexate Sales by Application (2019-2030)
5.1.1 Global Methotrexate Sales by Application (2019-2024)
5.1.2 Global Methotrexate Sales by Application (2025-2030)
5.1.3 Global Methotrexate Sales Market Share by Application (2019-2030)
5.2 Global Methotrexate Revenue by Application (2019-2030)
5.2.1 Global Methotrexate Revenue by Application (2019-2024)
5.2.2 Global Methotrexate Revenue by Application (2025-2030)
5.2.3 Global Methotrexate Revenue Market Share by Application (2019-2030)
5.3 Global Methotrexate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva Pharmaceutical Industries
6.1.1 Teva Pharmaceutical Industries Corporation Information
6.1.2 Teva Pharmaceutical Industries Description and Business Overview
6.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Pharmaceutical Industries Methotrexate Product Portfolio
6.1.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.2 Qualitestrx (DAVA Pharmaceuticals)
6.2.1 Qualitestrx (DAVA Pharmaceuticals) Corporation Information
6.2.2 Qualitestrx (DAVA Pharmaceuticals) Description and Business Overview
6.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Portfolio
6.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Developments/Updates
6.3 Pfizer (Hospira)
6.3.1 Pfizer (Hospira) Corporation Information
6.3.2 Pfizer (Hospira) Description and Business Overview
6.3.3 Pfizer (Hospira) Methotrexate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer (Hospira) Methotrexate Product Portfolio
6.3.5 Pfizer (Hospira) Recent Developments/Updates
6.4 Roxane Laboratories
6.4.1 Roxane Laboratories Corporation Information
6.4.2 Roxane Laboratories Description and Business Overview
6.4.3 Roxane Laboratories Methotrexate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roxane Laboratories Methotrexate Product Portfolio
6.4.5 Roxane Laboratories Recent Developments/Updates
6.5 Sine
6.5.1 Sine Corporation Information
6.5.2 Sine Description and Business Overview
6.5.3 Sine Methotrexate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sine Methotrexate Product Portfolio
6.5.5 Sine Recent Developments/Updates
6.6 Maoxiang
6.6.1 Maoxiang Corporation Information
6.6.2 Maoxiang Description and Business Overview
6.6.3 Maoxiang Methotrexate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Maoxiang Methotrexate Product Portfolio
6.6.5 Maoxiang Recent Developments/Updates
6.7 LingNan Pharmaceutical
6.6.1 LingNan Pharmaceutical Corporation Information
6.6.2 LingNan Pharmaceutical Description and Business Overview
6.6.3 LingNan Pharmaceutical Methotrexate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LingNan Pharmaceutical Methotrexate Product Portfolio
6.7.5 LingNan Pharmaceutical Recent Developments/Updates
6.8 Powerdone
6.8.1 Powerdone Corporation Information
6.8.2 Powerdone Description and Business Overview
6.8.3 Powerdone Methotrexate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Powerdone Methotrexate Product Portfolio
6.8.5 Powerdone Recent Developments/Updates
6.9 Huiyu
6.9.1 Huiyu Corporation Information
6.9.2 Huiyu Description and Business Overview
6.9.3 Huiyu Methotrexate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Huiyu Methotrexate Product Portfolio
6.9.5 Huiyu Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Methotrexate Industry Chain Analysis
7.2 Methotrexate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Methotrexate Production Mode & Process
7.4 Methotrexate Sales and Marketing
7.4.1 Methotrexate Sales Channels
7.4.2 Methotrexate Distributors
7.5 Methotrexate Customers
8 Methotrexate Market Dynamics
8.1 Methotrexate Industry Trends
8.2 Methotrexate Market Drivers
8.3 Methotrexate Market Challenges
8.4 Methotrexate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
